Crossmark

Tumour necrosis factor (TNF) antagonist therapy for paediatric inflammatory bowel disease: A systematic review

Crossref DOI link: https://doi.org/10.1016/j.medcle.2023.02.001

Published Print: 2023-06

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Martín-García, Paula

Alonso-Arroyo, Adolfo

Catalá-López, Ferrán
Funding

Funding for this research was provided by:

Instituto de Salud Carlos III

Centro de Investigación Biomédica en Red de Salud Mental
License Information

Text and Data Mining valid from 2023-06-01

stm-asf valid from 2023-06-01

stm-asf valid from 2023-06-01

stm-asf valid from 2023-06-01

stm-asf valid from 2023-06-01

stm-asf valid from 2023-06-01
More Information

This article is maintained by: Elsevier

Article Title: Tumour necrosis factor (TNF) antagonist therapy for paediatric inflammatory bowel disease: A systematic review

Journal Title: Medicina Clínica (English Edition)

CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.medcle.2023.02.001

CrossRef DOI link to the associated document: https://doi.org/10.1016/j.medcli.2023.02.006

Content Type: article

Copyright: © 2023 Elsevier España, S.L.U. All rights reserved.